NCT03208634 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Caimmi M, Carda S, Giovanzana C, Maini ES, Sabatini AM, Smania N, Molteni F
Using kinematic analysis to evaluate constraint-induced movement therapy in chronic stroke patients. Neurorehabil Neural Repair. 2008 Jan-Feb;22(1):31-9. Epub 2007 Jun 26.
Caimmi M, Guanziroli E, Malosio M, Pedrocchi N, Vicentini F, Molinari Tosatti L, Molteni F
Normative Data for an Instrumental Assessment of the Upper-Limb Functionality. Biomed Res Int. 2015;2015:484131. doi: 10.1155/2015/484131. Epub 2015 Oct 11.
Mehrholz J, Pohl M, Platz T, Kugler J, Elsner B
Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst Rev. 2015 Nov 7;(11):CD006876. doi: 10.
Norouzi-Gheidari N, Archambault PS, Fung J
Effects of robot-assisted therapy on stroke rehabilitation in upper limbs: systematic review and meta-analysis of the literature. J Rehabil Res Dev. 2012;49(4):479-96. Review.

La Riabilitazione Robot Assistita Del Paziente Neurologico: l'Elettromiografia Dinamica di Superficie Come Strumento Per la Personalizzazione Del Trattamento

Details for clinical trial NCT03208634

Clinical trial NCT03208634 - References